CN105377274A - 治疗或预防呼吸病症的方法 - Google Patents

治疗或预防呼吸病症的方法 Download PDF

Info

Publication number
CN105377274A
CN105377274A CN201380072492.9A CN201380072492A CN105377274A CN 105377274 A CN105377274 A CN 105377274A CN 201380072492 A CN201380072492 A CN 201380072492A CN 105377274 A CN105377274 A CN 105377274A
Authority
CN
China
Prior art keywords
cell
stro
cells
progeny
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380072492.9A
Other languages
English (en)
Chinese (zh)
Inventor
西尔维乌·伊泰斯库
拉维·克里希南
皮特·高希
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mesoblast Inc
Original Assignee
Mesoblast Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mesoblast Inc filed Critical Mesoblast Inc
Priority to CN202310100395.1A priority Critical patent/CN115919901A/zh
Publication of CN105377274A publication Critical patent/CN105377274A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CN201380072492.9A 2012-12-12 2013-12-12 治疗或预防呼吸病症的方法 Pending CN105377274A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310100395.1A CN115919901A (zh) 2012-12-12 2013-12-12 治疗或预防呼吸病症的方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12
US61/736,352 2012-12-12
PCT/AU2013/001454 WO2014089625A1 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202310100395.1A Division CN115919901A (zh) 2012-12-12 2013-12-12 治疗或预防呼吸病症的方法

Publications (1)

Publication Number Publication Date
CN105377274A true CN105377274A (zh) 2016-03-02

Family

ID=50933587

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201380072492.9A Pending CN105377274A (zh) 2012-12-12 2013-12-12 治疗或预防呼吸病症的方法
CN202310100395.1A Pending CN115919901A (zh) 2012-12-12 2013-12-12 治疗或预防呼吸病症的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202310100395.1A Pending CN115919901A (zh) 2012-12-12 2013-12-12 治疗或预防呼吸病症的方法

Country Status (11)

Country Link
US (3) US10028979B2 (enExample)
EP (1) EP2931373B1 (enExample)
JP (5) JP6313327B2 (enExample)
KR (1) KR101748712B1 (enExample)
CN (2) CN105377274A (enExample)
AU (4) AU2013360026B2 (enExample)
CA (1) CA2893951C (enExample)
ES (1) ES2759281T3 (enExample)
IL (1) IL239309A0 (enExample)
SG (2) SG11201504352TA (enExample)
WO (1) WO2014089625A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111093680A (zh) * 2017-09-15 2020-05-01 洋蓟治疗有限公司 治疗变应性气道疾病(aad)/哮喘的方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2893951C (en) 2012-12-12 2022-05-03 Mesoblast, Inc. Methods of treating or preventing respiratory conditions
US20170296589A1 (en) * 2014-09-23 2017-10-19 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
EP4098267A4 (en) * 2020-01-30 2024-03-06 JCR Pharmaceuticals Co., Ltd. MEDICINAL COMPOSITION COMPRISING CELLS DERIVED FROM DENTAL PULP
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1630717A (zh) * 2002-02-19 2005-06-22 美迪宝斯特有限公司 从脐带血中分离并扩大培养间充质干细胞 /祖细胞及将脐带血来源的间充质干细胞 /祖细胞分化成各种间充质组织的方法
CN101626772A (zh) * 2007-03-22 2010-01-13 奥西里斯治疗公司 间充质干细胞及其用途
WO2010025506A1 (en) * 2008-09-03 2010-03-11 Angioblast Systems, Inc. Expansion of haemopoietic precursors
CN101827603A (zh) * 2007-08-06 2010-09-08 成血管细胞系统公司 用于体内生成、修复和/或维护结缔组织的方法
CN101835889A (zh) * 2007-10-17 2010-09-15 特克赛尔公司 Tr1细胞、间充质干细胞和其用途
WO2012125471A1 (en) * 2011-03-11 2012-09-20 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
CN101506355B (zh) 2004-09-24 2012-06-27 成血管细胞系统公司 多能扩增间充质前体细胞子代（memp）及其应用
CN101248171B (zh) 2005-04-12 2015-11-25 迈索布拉斯特股份有限公司 通过组织非特异性碱性磷酸酶分离成人多潜能细胞
WO2008036374A2 (en) * 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
KR101891260B1 (ko) * 2010-07-02 2018-08-24 메소블라스트, 아이엔씨. T-세포 매개된 면역 질환의 치료
AU2012262675B2 (en) 2011-06-03 2016-05-19 Mesoblast, Inc Methods of treating or preventing neurological diseases
CA2893951C (en) 2012-12-12 2022-05-03 Mesoblast, Inc. Methods of treating or preventing respiratory conditions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1630717A (zh) * 2002-02-19 2005-06-22 美迪宝斯特有限公司 从脐带血中分离并扩大培养间充质干细胞 /祖细胞及将脐带血来源的间充质干细胞 /祖细胞分化成各种间充质组织的方法
CN101626772A (zh) * 2007-03-22 2010-01-13 奥西里斯治疗公司 间充质干细胞及其用途
CN101827603A (zh) * 2007-08-06 2010-09-08 成血管细胞系统公司 用于体内生成、修复和/或维护结缔组织的方法
CN101835889A (zh) * 2007-10-17 2010-09-15 特克赛尔公司 Tr1细胞、间充质干细胞和其用途
WO2010025506A1 (en) * 2008-09-03 2010-03-11 Angioblast Systems, Inc. Expansion of haemopoietic precursors
CN102144028A (zh) * 2008-09-03 2011-08-03 成血管细胞系统公司 造血前体的扩增
WO2012125471A1 (en) * 2011-03-11 2012-09-20 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111093680A (zh) * 2017-09-15 2020-05-01 洋蓟治疗有限公司 治疗变应性气道疾病(aad)/哮喘的方法

Also Published As

Publication number Publication date
US20200289578A1 (en) 2020-09-17
IL239309A0 (en) 2015-07-30
WO2014089625A1 (en) 2014-06-19
AU2018226514A1 (en) 2018-09-27
CA2893951A1 (en) 2014-06-19
US10688134B2 (en) 2020-06-23
HK1210077A1 (en) 2016-04-15
US10028979B2 (en) 2018-07-24
JP2020097618A (ja) 2020-06-25
AU2020202022A1 (en) 2020-04-09
AU2013360026A1 (en) 2015-07-02
US20190046575A1 (en) 2019-02-14
JP2024041904A (ja) 2024-03-27
EP2931373B1 (en) 2019-08-21
US20150306146A1 (en) 2015-10-29
JP6665218B2 (ja) 2020-03-13
JP2016502980A (ja) 2016-02-01
EP2931373A1 (en) 2015-10-21
KR101748712B1 (ko) 2017-06-19
SG11201504352TA (en) 2015-07-30
AU2013360026B2 (en) 2018-06-21
AU2022209219A1 (en) 2022-08-18
JP2022065132A (ja) 2022-04-26
ES2759281T3 (es) 2020-05-08
JP2018118987A (ja) 2018-08-02
AU2022209219B2 (en) 2025-08-14
KR20150090237A (ko) 2015-08-05
JP7420844B2 (ja) 2024-01-23
EP2931373A4 (en) 2016-05-04
CN115919901A (zh) 2023-04-07
CA2893951C (en) 2022-05-03
JP6313327B2 (ja) 2018-04-18
SG10201807682PA (en) 2018-10-30
AU2018226514B2 (en) 2020-01-02

Similar Documents

Publication Publication Date Title
CN105377274A (zh) 治疗或预防呼吸病症的方法
JP6315989B2 (ja) Ｔ細胞性免疫不全の治療法
JP6184942B2 (ja) 神経疾患を治療するまたは予防する方法
JP2018016639A (ja) リウマチ性疾患を予防または治療する方法
TR201809635T4 (tr) Osteoblastik fonksiyonun arttırılmasına yönelik yöntemler.
ES2742035T3 (es) Tratamiento de las enfermedades de la disfunción y la inflamación endotelial
US20240024366A1 (en) Methods of treating or preventing respiratory conditions
JP2009521459A (ja) 肝機能障害治療において肝前駆細胞を用いる方法
HK1210077B (en) Methods of treating or preventing respiratory conditions
CN101378774A (zh) 用干扰素治疗肺病的方法
HK1196541B (en) Methods of treating or preventing neurological diseases
HK1196541A (en) Methods of treating or preventing neurological diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160302

RJ01 Rejection of invention patent application after publication